Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program

Neuro-Oncology

Volumn 9, Issue 4, 2007, Pages 430-437

  Via, Paola Dalla ^a   Opocher, Enrico ^a   Pinello, Maria Luisa ^a   Calderone, Milena ^a   Viscardi, Elisabetta ^a   Clementi, Maurizio ^a   Battistella, Pier Antonio ^a   Laverda, Anna Maria ^a   Dalt, Liviana Da ^a   Perilongo, Giorgio ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Chemotherapy; Neurofibromatosis type 1; Optic pathway glioma; Radiotherapy; Visual function

Indexed keywords

CARBOPLATIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EYE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROFIBROMATOSIS; OPTIC NERVE GLIOMA; PATIENT REFERRAL; PEDIATRICS; RADIATION DOSE; TUMOR VOLUME; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; CLINICAL TRIAL; CONTRAST SENSITIVITY; DRUG EFFECT; EVOKED VISUAL RESPONSE; INFANT; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; RADIATION EXPOSURE; RADIOTHERAPY; VISUAL DISORDER;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CONTRAST SENSITIVITY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; INFANT; MALE; NEUROFIBROMATOSIS 1; OPTIC NERVE GLIOMA; RADIOTHERAPY; VINCRISTINE; VISION DISORDERS; VISUAL FIELDS;

EID: 38449086605     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2007-031     Document Type: Article

References (17)

1. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol. 1997;41:143-149.
2. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestation and natural history. J Pediatr. 1995;127:718-722.
3. Rosser T, Packer RJ. Intracranial neoplasms in children with neurofibromatosis 1. J Child Neurol. 2002;17:630-637.
4. Garvey M, Packer RJ. An integrated approach to the treatment of chiasmatic-hypothalamic gliomas. J Neurooncol. 1996;28:167-183.
5. Laithier V, Grill J, Le Deley M, et al. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy-results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol. 2003;21:4572-4578.
6. Gnekow AK, Kortmann RD, Pietsch T, Emser A. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy-report from the Multicenter Treatment Study for Children and Adolescents with a Low Grade Glioma-HIT-LGG 1996-of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr. 2004;216:331-342.
7. King A, Listernick R, Charrow J, Piersall L, Gutmann DH. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am J Med Genet. 2003;122A:95-99.
8. Massimino M, Spreafico F, Cefalo G, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol. 2002;20:4209-4216.
9. Kortmann RD, Timmermann B, Taylor RE, et al. Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part II: treatment-related late toxicity. Strahlenther Onkol. 2003; 179:585-597.
10. De Bella K, Szudek J, Friedman JM. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105;608-614.
11. Dodge HJ, Love J, Craig W, et al. Gliomas of the optic nerves. AMA Arch Neurol Psychiatry. 1958;79:607-621.
12. Balcer LJ, Liu GT, Heller G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol. 2001;131:442-445.
13. Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer. 1995;75:1051-1059.
14. Sutton LN, Molloy PT, Sernyak H, et al. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg. 1995;83:583-589.
15. Thiagalingam S, Flaherty M, Billson F, North K. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology. 2004;111:568-577.
16. Gayre GS, Scott IU, Feuer W, Saunders TG, Siatkowski RM. Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol. 2001;21:1-7.
17. Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol. 2003;28:262-270.